WASHINGTON, United States: (AFP) Pfizer said on Tuesday (Dec 14) that clinical trials confirmed its Covid-19 pill – a new type of treatment that should withstand the mutations seen with the Omicron variant – drastically reduced hospitalisations and deaths among at-risk people by almost 90%.
The announcement, which was praised by US President Joe Biden, came as a real-world study from South Africa showed two doses of the Pfizer-BioNTech vaccine was 70% effective in stopping severe illness from the new strain.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!